Russell Investments Group, Ltd. - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$214,034
+23.9%
187,750
-0.6%
0.00%
Q2 2023$172,767
+63.3%
188,8180.0%0.00%
Q1 2023$105,812
-4.5%
188,818
-1.6%
0.00%
Q4 2022$110,772
+84.6%
191,983
-2.0%
0.00%
Q3 2022$60,000
-23.1%
195,915
-13.2%
0.00%
Q2 2022$78,000
-57.1%
225,640
-11.8%
0.00%
Q1 2022$182,000
-74.5%
255,967
-19.0%
0.00%
-100.0%
Q4 2021$713,000
-39.0%
316,047
-22.3%
0.00%
-50.0%
Q3 2021$1,169,000
-32.7%
406,680
-11.4%
0.00%
-33.3%
Q2 2021$1,738,000
+13.6%
459,080
+1.5%
0.00%0.0%
Q1 2021$1,530,000
+23.2%
452,409
+1.9%
0.00%
+50.0%
Q4 2020$1,242,000
+156.6%
443,789
+128.8%
0.00%
+100.0%
Q3 2020$484,000
-86.7%
193,977
-27.6%
0.00%
-87.5%
Q2 2020$3,632,000
+312.7%
267,888
+130.7%
0.01%
+300.0%
Q1 2020$880,000
+22.9%
116,120
+2.4%
0.00%
+100.0%
Q4 2019$716,000
+62.0%
113,361
+110.1%
0.00%0.0%
Q1 2019$442,000
+52.9%
53,960
+3.1%
0.00%0.0%
Q4 2018$289,000
+7.8%
52,332
+72.0%
0.00%0.0%
Q3 2018$268,000
+13.6%
30,432
+29.1%
0.00%
Q2 2018$236,000
-46.4%
23,572
-49.0%
0.00%
-100.0%
Q1 2018$440,000
-28.1%
46,209
+16.8%
0.00%0.0%
Q4 2017$612,000
-59.9%
39,546
-49.1%
0.00%
-66.7%
Q3 2017$1,527,000
+51.8%
77,640
+10.8%
0.00%
+50.0%
Q2 2017$1,006,000
+22.2%
70,069
-21.7%
0.00%0.0%
Q1 2017$823,000
+641.4%
89,467
+734.2%
0.00%
Q4 2016$111,00010,7250.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,031,283$95,485,0005.72%
GREAT POINT PARTNERS LLC 3,510,073$47,667,0003.81%
Logos Global Management LP 1,200,000$16,296,0003.26%
DAFNA Capital Management LLC 762,666$10,357,0002.99%
Baupost Group 15,000,000$203,700,0002.54%
Nantahala Capital Management 6,101,111$82,853,0002.50%
Abrams Capital Management 5,656,462$76,815,0002.48%
Novo Holdings A/S 1,987,506$26,990,0001.74%
Stanley-Laman Group, Ltd. 316,933$4,304,0001.04%
Integral Health Asset Management, LLC 250,000$3,395,0001.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders